Skip to main content
SpringerLink
Log in

Bacteria in the Genitourinary Tract: The Microbiota and Probiotics

  • Chapter
The Role of Bacteria in Urology

  • 762 Accesses

Abstract

The identification of an array of bacterial species in the urinary tract, detected by DNA sequencing, has the potential to change many aspects of urological practice. If they are associated with health or disease, should all urines be sampled as part of patient management, and what is the consequence of antibiotic therapy? Can an aberrant microbiota be manipulated by probiotics, drugs or diet resulting in less risk or better control of disease? To answer these questions, more microbiome studies are needed along with methods that interpret the data in a clinically relevant manner. Cause and effect remains to be established in most cases, but this area has the potential to invigorate urological research and improve patient care in the not so distant future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fowler Jr. JE, Latta R, Stamey TA. Studies of introital colonization in women with recurrent urinary infections. VIII. The role of bacterial interference. J Urol. 1977;118(2):296–8.

    PubMed  Google Scholar 

  2. Reid G, Younes J, van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2011;9(1):27–38.

    Article  CAS  PubMed  Google Scholar 

  3. Brumbaugh AR, Mobley HL. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines. 2012;11(6):663–76.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Issack MI, Yee Kin Tet HY, Morlat P. Antimicrobial resistance among Enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius: consequences of past misuse of antibiotics. J Chemother. 2007;19(2):222–5.

    Article  CAS  PubMed  Google Scholar 

  5. Hooton TM, Levy SB. Antimicrobial resistance: a plan of action for community practice. Am Fam Physician. 2001;63(6):1087–98.

    CAS  PubMed  Google Scholar 

  6. Theoharides TC. Treatment approaches for painful bladder syndrome/interstitial cystitis. Drugs. 2007;67(2):215–35.

    Article  CAS  PubMed  Google Scholar 

  7. Guay DR. Cranberry and urinary tract infections. Drugs. 2009;69(7):775–807.

    Article  CAS  PubMed  Google Scholar 

  8. Wolfe AJ, Toh E, Shibata N, Rong R, Kenton K, Fitzgerald M, Mueller ER, Schreckenberger P, Dong Q, Nelson DE, Brubaker L. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50:1376–83.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Nelson DE, Van Der Pol B, Dong Q, Revanna KV, Fan B, Easwaran S, Sodergren E, Weinstock GM, Diao L, Fortenberry JD. Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection. PLoS One. 2010;5(11):e14116.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Nelson DE, Dong Q, Van der Pol B, Toh E, Fan B, Katz BP, Mi D, Rong R, Weinstock GM, Sodergren E, Fortenberry JD. Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS One. 2012;7(5):e36298.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Fouts DE, Pieper R, Szpakowski S, Pohl H, Knoblach S, Suh MJ, Huang ST, Ljungberg I, Sprague BM, Lucas SK, Torralba M, Nelson KE, Groah SL. Integrated next-generation sequencing of 16S rDNA and metaproteomics differentiate the healthy urine microbiome from asymptomatic bacteriuria in neuropathic bladder associated with spinal cord injury. J Transl Med. 2012;10:174.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Cubero N, Esteban J, Palenque E, Rosell A, Garcia MJ. Evaluation of the detection of Mycobacterium tuberculosis with metabolic activity in culture-negative human clinical samples. Clin Microbiol Infect. 2013;19(3):273–8.

    Article  CAS  PubMed  Google Scholar 

  13. Sonderegger M, Schümperli M, Sauer U. Selection of quiescent Escherichia coli with high metabolic activity. Metab Eng. 2005;7(1):4–9.

    Article  CAS  PubMed  Google Scholar 

  14. Kirjavainen P, Pautler S, Baroja ML, Anukam K, Crowley K, Carter K, Reid G. Aberrant vaginal microbiota and IL-12 skewed cytokine production by antigen-presenting cells are characteristic of women prone to urinary tract infections. Clin Vaccine Immunol. 2008;16(1):29–36.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Borre YE, Moloney RD, Clarke G, Dinan TG, Cryan JF. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol. 2014;817:373–403.

    Article  CAS  PubMed  Google Scholar 

  16. Forsythe P, Bienenstock J, Kunze WA. Vagal pathways for microbiome-brain-gut axis communication. Adv Exp Med Biol. 2014;817:115–33.

    Article  PubMed  Google Scholar 

  17. Pearce MM, Hilt EE, Rosenfeld AB, Zilliox MJ, Thomas-White K, Fok C, Kliethermes S, Schreckenberger PC, Brubaker L, Gai X, Wolfe AJ. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio. 2014;5(4):e01283-14.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Reid G. Neuroactive probiotics. Bioessays. 2011;33(8):562.

    Article  PubMed  Google Scholar 

  19. Fricke WF, Maddox C, Song Y, Bromberg JS. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14(2):416–27.

    Article  CAS  PubMed  Google Scholar 

  20. Urbaniak C, McMillan A, Angelini M, Gloor GB, Sumarah M, Burton JP, Reid G. Effect of chemotherapy on the microbiota and metabolome of human milk, a case report. Microbiome. 2014;2:24.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Paintsil E. Update on recent guidelines for the management of urinary tract infections in children: the shifting paradigm. Curr Opin Pediatr. 2013;25(1):88–94.

    Article  PubMed  Google Scholar 

  22. Chaussade H, Sunder S, Bernard L, Coloby P, Guy L, Karsenty G, Bastide C, Bruyère F. Antibiotic treatments in urology. Prog Urol. 2013;23(15):1327–41.

    Article  CAS  PubMed  Google Scholar 

  23. Mori R, Fitzgerald A, Williams C, Tullus K, Verrier-Jones K, Lakhanpaul M. Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systematic review. Acta Paediatr. 2009;98(11):1781–6.

    Article  PubMed  Google Scholar 

  24. Dell JR. Interstitial cystitis/painful bladder syndrome: appropriate diagnosis and management. J Womens Health (Larchmt). 2007;16(8):1181–7.

    Article  Google Scholar 

  25. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes (Lond). 2013;37(1):16–23.

    Article  CAS  Google Scholar 

  26. Bailey RR. Single oral dose treatment of uncomplicated urinary tract infection in women. Chemotherapy. 1996;42 Suppl 1:10–6.

    Article  CAS  PubMed  Google Scholar 

  27. Bleidorn J, Gágyor I, Kochen MM, Wegscheider K, Hummers-Pradier E. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? Results of a randomized controlled pilot trial. BMC Med. 2010;8:30.

    Article  PubMed Central  PubMed  Google Scholar 

  28. Reid G, Chan RCY, Bruce AW, Costerton JW. Prevention of urinary tract infection in rats with an indigenous Lactobacillus casei strain. Infect Immun. 1985;49(2):320–4.

    PubMed Central  CAS  PubMed  Google Scholar 

  29. Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract. J Urol. 1987;138:330–5.

    CAS  PubMed  Google Scholar 

  30. Reid G, Cook RL, Hagberg L, Bruce AW. Lactobacilli as competitive colonizers of the urinary tract. In: Kass EH, Svanborg Eden C, editors. Host- parasite interactions in urinary tract infections. Chicago: University of Chicago Press; 1989. p. 390–6.

    Google Scholar 

  31. Hagberg L, Bruce AW, Reid G, Svanborg Eden C, Lincoln K, Lidin-Janson G. Colonization of the urinary tract with live bacteria from the normal fecal and urethral flora in patients with recurrent symptomatic urinary tract infections. In: Kass EH, Svanborg Eden C, editors. Host-parasite interactions in urinary tract infections. Chicago: University of Chicago Press; 1989. p. 194–7.

    Google Scholar 

  32. Darouiche RO, Green BG, Donovan WH, Chen D, Schwartz M, Merritt J, Mendez M, Hull RA. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology. 2011;78(2):341–6.

    Article  PubMed  Google Scholar 

  33. Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301(5629):105–7.

    Article  CAS  PubMed  Google Scholar 

  34. Goneau LW, Yeoh NS, MacDonald KW, Cadieux PA, Burton JP, Razvi H, Reid G. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Antimicrob Agents Chemother. 2014;58(4):2089–97.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Reid G, Bruce AW, Cook RL, Llano M. Effect on the urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis. 1990;22:43–7.

    Article  CAS  PubMed  Google Scholar 

  36. Stokholm J, Schjørring S, Eskildsen CE, Pedersen L, Bischoff AL, Følsgaard N, Carson CG, Chawes BL, Bønnelykke K, Mølgaard A, Jacobsson B, Krogfelt KA, Bisgaard H. Antibiotic use during pregnancy alters the commensal vaginal microbiota. Clin Microbiol Infect. 2014;20(7):629–35.

    Article  CAS  PubMed  Google Scholar 

  37. Gilbert NM, O’Brien VP, Hultgren S, Macones G, Lewis WG, Lewis AL. Urinary tract infection as a preventable cause of pregnancy complications: opportunities, challenges, and a global call to action. Glob Adv Health Med. 2013;2(5):59–69.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Saunders S, Bocking A, Challis J, Reid G. Disruption of Gardnerella vaginalis biofilms by Lactobacillus. Colloids Surf B Biointerfaces. 2007;55(2):138–42.

    Article  CAS  PubMed  Google Scholar 

  39. McMillan A, Dell M, Zellar MP, Cribby S, Martz S, Hong E, Fu J, Abbas A, Dang T, Miller W, Reid G. Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces. 2011;86:58–64.

    Article  CAS  PubMed  Google Scholar 

  40. Lee SJ, Shim YH, Cho SJ, Lee JW. Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(9):1315–20.

    Article  PubMed  Google Scholar 

  41. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995;23:32–45.

    Google Scholar 

  42. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaya Y, Fiedler T, Cox M, Stamm WE. Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis. 2011;52(10):1212–7.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Beerepoot MA, ter Riet G, Nys S, van der Wal WM, de Borgie CA, de Reijke TM, Prins JM, Koeijers J, Verbon A, Stobberingh E, Geerlings SE. Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med. 2012;172(9):704–12.

    Article  CAS  PubMed  Google Scholar 

  44. Ciani O, Grassi D, Tarricone R. An economic perspective on urinary tract infection: the “costs of resignation”. Clin Drug Investig. 2013;33(4):255–61.

    Article  PubMed  Google Scholar 

  45. Nicholson JK, Everett JR, Lindon JC. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Expert Opin Drug Metab Toxicol. 2012;8(2):135–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Human Microbiome and Probiotics, Lawson Health Research Institute, 268 Grosvenor Street, London, ON, N6A 4V2, Canada

    Gregor Reid BSc (Hons), PhD, MBA, Dr HS

  2. Microbiology & Immunology, and Surgery, The University of Western Ontario, London, ON, Canada

    Gregor Reid BSc (Hons), PhD, MBA, Dr HS

Authors
  1. Gregor Reid BSc (Hons), PhD, MBA, Dr HS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregor Reid BSc (Hons), PhD, MBA, Dr HS .

Editor information

Editors and Affiliations

  1. Basic Science Research, The Stone Centre at Vancouver General Hospital, Vancouver, British Columbia, Canada

    Dirk Lange

  2. Clinical Research, The Stone Center at Vancouver General Hospital, Vancouver, British Columbia, Canada

    Ben Chew

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Reid, G. (2016). Bacteria in the Genitourinary Tract: The Microbiota and Probiotics. In: Lange, D., Chew, B. (eds) The Role of Bacteria in Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-17732-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17732-8_1

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17731-1

  • Online ISBN: 978-3-319-17732-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation